Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effect (original) (raw)

Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation

Stephen Lowis

Cancer research, 1993

View PDFchevron_right

A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children

Stephen Lowis

British journal of cancer, 1998

View PDFchevron_right

A limited sampling model for the pharmacokinetics of etoposide given orally

Valter Torri

Cancer Chemotherapy and Pharmacology, 1993

View PDFchevron_right

Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters

Huw Thomas

Journal of Pharmacokinetics and Biopharmaceutics, 1996

View PDFchevron_right

Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors

Paul Hutson

Cancer research, 1984

View PDFchevron_right

Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer

Joseph Sinkule

Cancer Chemotherapy and Pharmacology, 1982

View PDFchevron_right

Plasma Etoposide Catechol Increases in Pediatric Patients Undergoing Multiple-Day Chemotherapy with Etoposide

Shaokun Pang, Naiyu Zheng

Clinical Cancer Research, 2004

View PDFchevron_right

Cyclophosphamide pharmacokinetics in children

MICHAEL COLE

British Journal of Clinical Pharmacology, 1996

View PDFchevron_right

Overview of Clinical Pharmacokinetics in Pediatrics: Possible Implications in Therapy

Herbert Obu

Biomedical & Pharmacology Journal, 2014

View PDFchevron_right

Etoposide for the treatment of paediatric tumours: What is the best way to give it?

S. Lowis

European Journal of Cancer, 1996

View PDFchevron_right

957 Bioavailability and pharmacokinetics of oral etoposide (VP16) in elderly patients

Antonio Lucenti

European Journal of Cancer, 1995

View PDFchevron_right

Bioavailability of Etoposide after Oral Administration of the Solution Marketed for Intravenous Use

Jaime de la Garza Salazar, Gilberto Castañeda-Hernández

Archives of Medical Research, 1999

View PDFchevron_right

Developmental Pharmacokinetics: Drug Disposition Relative to Age

Michelle Bestic

2014

View PDFchevron_right

Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential Effect

A. Gaedigk

Drug Metabolism and Disposition, 2010

View PDFchevron_right

A Universal Pharmacokinetic Model for Dexmedetomidine in Children and Adults

Ignacio Cortinez

Journal of Clinical Medicine, 2020

View PDFchevron_right

Pharmacokinetics of cyclophosphamide and its metabolites in pediatric patients receiving high-dose myeloablative therapy

MICHAEL COLE

2011

View PDFchevron_right

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

Pilar Tejada

Pharmaceutics, 2011

View PDFchevron_right

The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide

Atholl Johnston

British journal of cancer, 1985

View PDFchevron_right

Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling

francois bouzom

Fundamental & Clinical Pharmacology, 2008

View PDFchevron_right

Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age

Mika Scheinin

British Journal of Anaesthesia, 2008

View PDFchevron_right

Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients

MICHAEL COLE

Cancer Chemotherapy and Pharmacology, 2010

View PDFchevron_right

A pharmacokinetic standard for babies and adults

Nick Holford

Journal of Pharmaceutical Sciences, 2013

View PDFchevron_right

Pharmacokinetics of Ethionamide in Children

H. Schaaf

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug Literature

Dale Hattis, Rob Goble

Toxicological Sciences, 2002

View PDFchevron_right

HPLC Determination of Etoposide in Injectable Dosage Forms

Muhammad Aneeb Ashraf

Journal of the Chilean Chemical Society, 2011

View PDFchevron_right

Newborns, Older Children, and Adults Comparisons of Pharmacokinetics and Pharmacokinetic Variability

Robert Goble

View PDFchevron_right

How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians

Eric Vermeulen

Journal of Pharmacy and Pharmacology

View PDFchevron_right

Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide

Rakesh Johri

Journal of Biosciences, 2014

View PDFchevron_right

Pharmacokinetic studies in children: recommendations for practice and research

Allison Needham

Archives of Disease in Childhood, 2018

View PDFchevron_right

High-dose etoposide formulations do not saturate intestinal P-glycoprotein: Development, stability, and pharmacokinetics in Sprague-Dawley rats

An Vermeulen

International Journal of Pharmaceutics, 2020

View PDFchevron_right